Sort
48,018 grants matching “immunotherapy”
Targeting colorectal cancer stem cells with ALDH1B1 antagonists
$439,838James K Chen · Stanford University · R01 · FY2025 · CA
Project 2 - Genomics of Allogeneic Transplantation.
$439,823John F Dipersio · Washington University · P01 · FY2021 · CA
Metastatic Clonal Heterogeneity and its Impact on Melanoma Therapeutic Resistance
$439,813Willy Hugo · University Of California Los Angeles · R01 · FY2024 · CA
Structural and functional analyses of the RIG-I filament in innate immunity
$439,792Sun Hur · Boston Children'S Hospital · R01 · FY2014 · AI
Quantitative modeling of the collective tuning of T cell activation.
$439,750Morgan A Huse · Sloan-Kettering Inst Can Research · R56 · FY2015 · AI
Project 3: Combinatorial and gene-editing approaches to enhance the efficacy of CAR T cell therapy of multiple myeloma.
$439,749Edward A Stadtmauer · University Of Pennsylvania · P01 · FY2020 · CA
Enhancement of stem cell transplants using CAR.CD30-redirected T lymphocytes
$439,742Barbara Savoldo · Baylor College Of Medicine · R01 · FY2013 · HL
MusIC: A multi-scale technology for integrating dynamic cellular function and molecular profiles
$439,696Navin Varadarajan · University Of Houston · R01 · FY2022 · GM
The CXCR3 Chemokine System in Cancer Immunotherapy
$439,649Andrew D Luster · Massachusetts General Hospital · R01 · FY2017 · CA
Tumor and Immune Programming of Tumor-Associated Endothelium
$439,634Eugene C Butcher · Palo Alto Veterans Instit For Research · R01 · FY2020 · CA
Repertoire selection of AQP4-specific T cells that cause CNS autoimmunedisease
$439,508Scott S Zamvil · University Of California, San Francisco · R01 · FY2023 · AI
Project 1: Targeting the PD-1 pathway in HCC
$439,497Ahmed Kaseb · University Of Tx Md Anderson Can Ctr · P50 · FY2021 · CA
Role of heat shock transcription factors (HSFs) in hematological malignancies
$439,457Nahid F Mivechi · Augusta University · R01 · FY2024 · CA
Mechanism of Heterochromatin Assembly and epigenetic inheritance
$439,416Songtao Jia · Columbia Univ New York Morningside · R35 · FY2025 · GM
Mechanism of Heterochromatin Assembly and epigenetic inheritance
$439,416Songtao Jia · Columbia Univ New York Morningside · R35 · FY2024 · GM
Specific Adoptive Immunotherapy of Myeloid Malignancy
$439,383Philip D Greenberg · Fred Hutchinson Cancer Research Center · P01 · FY2013 · CA
Immune regulation of tissue iron in health and disease
$439,377Nicholas J. Bessman · Rutgers Biomedical And Health Sciences · DP2 · FY2025 · AI
Project 1: Innate immune responses triggered by Listeria monocytogenes
$439,375Daniel A Portnoy · University Of California Berkeley · P01 · FY2016 · AI
Cell-targeted glutamine antagonists as a novel therapy for lymphoma
$439,350Barbara Stauch Slusher · Johns Hopkins University · R01 · FY2019 · CA
SUPR Peptides to Inhibit Undruggable Cancer Target (PQ18)
$439,344Richard W Roberts · University Of Southern California · R01 · FY2014 · CA
Targeting TERT in Melanoma
$439,320Jessie Villanueva · Wistar Institute · R01 · FY2018 · CA
Novel Potent Autophagy Inhibitors for Melanoma
$439,280Jeffrey D Winkler · Wistar Institute · P01 · FY2014 · CA
Humanized mouse models to dissect in vivo the interplay between melanoma and the immune system
$439,280Anna Karolina Palucka · Jackson Laboratory · R01 · FY2017 · CA
Acquisition of a Cell Sorter for Systems Biology and Cellular Engineering
$439,244Lukasz Bugaj · University Of Pennsylvania · S10 · FY2020 · OD
Metabolic Barriers to T Cell Activation in Clear Cell Renal Cell Carcinoma
$439,237Jeffrey C Rathmell · Vanderbilt University Medical Center · R01 · FY2021 · CA